Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric.

Slides:



Advertisements
Similar presentations
J Exp Bot. 2017;68(17): doi: /jxb/erx352
Advertisements

Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. Overview of the workflow of NetworkAnalyst 3.0.
Figure 1 The study area within Vienna Zoo is outlined in red
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Top: Annual modal paternity distance (PDc) estimated for each of 23 cohorts by MasterBayes ... Figure 1 Top: Annual modal paternity distance (PDc)
Figure 1 Study area in Northern Wisconsin, USA, where we simulated the dispersal of 15 translocated American martens ... Figure 1 Study area in Northern.
Figure 1 Flow diagram detailing the systematic review process.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:
Figure 1. Linkage analyses of the SNPs in the MRE11 gene and haplotype blocks. Haplotype blocks were defined for all ... Figure 1. Linkage analyses of.
Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.
Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.
RCTs: randomized controlled ...
Fig. 1 Mean change from baseline in ANC ± s. e
Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).
Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.
Fig. 1 Flow chart of included patients for analyses
Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.
Fig. 1 Flow chart for selection of study subjects
Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.
Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.
FIGURE 1 Malta: a plate-style food guide
Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.
FIGURE 1 Study consort diagram
Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,
Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.
Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.
Figure 1. Using Voronoi tessellation to define contacts
Figure 4. RLS spectra of (A) TMPipEOPP and (B) OMHEPzEOPP in the presence of different concentrations of KRAS. The RLS ... Figure 4. RLS spectra of (A)
Figure 1 MIC test strips showing reversion of daptomycin resistance of isolate 5 passaged in vitro. This figure ... Figure 1 MIC test strips showing reversion.
Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.
Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.
Figure 1. Trunk and leg fat over study period. LS, log transformed.
Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.
Figure 1. Time to clinical stability (a) and time to defervescence (b) in patients with pneumococcal pneumonia. ... Figure 1. Time to clinical stability.
Figure 1. (A) Architecture of Doc2Hpo. (B) Interactive user interface
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.
Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a ... Figure 1. Overview of features.
Figure 1 Patient disposition
Figure 1 Distribution of WCD use days in WEARIT-II
Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.
Figure 1. Genetic context of blaNDM-21 on pNDM21_020023
Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.
Figure 1 Genetic results. No case had more than one diagnostic result
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Figure 1. (A) Baseline contrast-enhanced CT scan of melanoma patient presenting with metastases in the liver and lymph ... Figure 1. (A) Baseline contrast-enhanced.
Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.
Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.
Source:Zimnisky (2014). Source:Zimnisky (2014).
Figure 1 Mechanisms of mitral regurgitation.
FIGURE 1 Changes in lipids and lipoproteins after consuming a Med-Red or Med-Control diet for 5 wk. Results are ... FIGURE 1 Changes in lipids and lipoproteins.
Figure 2. Model adequacy results for the two empirical data sets, West African Ebola, and 2009 H1N1 influenza. The ... Figure 2. Model adequacy results.
Fig. 1. Examples of plots of NanoPlot and NanoComp
Figure 1 ABCDE of primary prevention.2
Figure 1. Hepatitis C screening and diagnostic algorithm at the MSF clinic, Karachi, Pakistan, March 2016–September ... Figure 1. Hepatitis C screening.
Figure 1. Forest plot of lung cancer mortality in LDCT trials.
Table 2. Mean noise level results for hand dryers in dBA
Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.
Presentation transcript:

Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and proportions of 396 individual caregivers or parents of children aged <5 years residing in the study area (x-axis) selecting the various healthcare services (y-axis) as first, second or third choices (see key for shading) for watery and mucoid diarrhoea. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, https://doi.org/10.1093/jac/dky231 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3. Medications sold by pharmacies in the study area for paediatric diarrhoea. (a) Rotated histogram showing the ... Figure 3. Medications sold by pharmacies in the study area for paediatric diarrhoea. (a) Rotated histogram showing the number and proportion (x-axis) of the 37 pharmacies visited during the ‘mystery shopper’ simulated client method selling between 1 and 5 medications (y-axis) for watery and mucoid diarrhoea, respectively. (b) Rotated histogram showing the number and proportion (x-axis) of the 37 pharmacies visited during the ‘mystery shopper’ simulated client method selling different mediations (y-axis) for watery and mucoid diarrhoea, respectively. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, https://doi.org/10.1093/jac/dky231 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 2. The geographical distribution of pharmacies in the Ho Chi Minh City study area. Maps of district 8 in Ho Chi ... Figure 2. The geographical distribution of pharmacies in the Ho Chi Minh City study area. Maps of district 8 in Ho Chi Minh City. (a) The point locations of pharmacies and the kernel distribution of pharmacy shop density. Green points identify the pharmacy shops and pharmacy density is determined by colour intensity (see key). (b) The distribution of pharmacy shops density per 10 000 inhabitants. The greater the intensity of red the higher the number of pharmacy shops per 10 000 people (see key, areas in grey are those with no data owing to missing data in the population raster). (c) The geographical areas in District 8 that are within 250 m of a pharmacy. Red shaded areas are locations in which residents live with 250 m of a location selling antimicrobials. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, https://doi.org/10.1093/jac/dky231 The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 1. Estimating antimicrobial usage for diarrhoea in children aged 1–5 years in pharmacies and hospital. Diagram ... Figure 1. Estimating antimicrobial usage for diarrhoea in children aged 1–5 years in pharmacies and hospital. Diagram outlining the sources of data, parameters, and calculations used to quantify antimicrobial usage for diarrhoea in children aged 1–5 years in this population. Note each of the parameters have been given an initial (A–F), which informs the calculations in Table 3. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. J Antimicrob Chemother, Volume 73, Issue 9, 04 July 2018, Pages 2546–2554, https://doi.org/10.1093/jac/dky231 The content of this slide may be subject to copyright: please see the slide notes for details.